Inventor · disambiguated record
Moise A. Khayrallah
Also filed as: KHAYRALLAH MOISE A
16 granted patents·11 pending applications·473 citations·filing 2008–2024
95Inventor score
Files withAXSOME MALTA LTD5SK BIOPHARMACEUTICALS CO LTD5HORACEK HENRY JOSEPH3JAZZ PHARMACEUTICALS INT III LTD2JAZZ PHARMACEUTICALS INTERNAT III LTD2
Top patents by PatentIndex Score
27 records- 0198US10259780B2Treatment of cataplexyJAZZ PHARMACEUTICALS INTERNATIONAL III LTD·Filed 2017·Granted Apr 16, 2019·53 cites·12 claims
- 0297US10105341B2Treatment for obesityJAZZ PHARMACEUTICALS INTERNATIONAL III LTD·Filed 2017·Granted Oct 23, 2018·36 cites·20 claims
- 0397US9649291B2Treatment for obesityJAZZ PHARMACEUTICALS INT III LTD·Filed 2015·Granted May 16, 2017·57 cites·20 claims
- 0497US9585863B2Treatment of cataplexyJAZZ PHARMACEUTICALS INT III LTD·Filed 2016·Granted Mar 7, 2017·53 cites·22 claims
- 0596US11072579B2Treatment of cataplexyJAZZ PHARMACEUTICALS INTERNATIONAL ILL LTD·Filed 2019·Granted Jul 27, 2021·53 cites·12 claims
- 0696US9359290B2Treatment of cataplexyJAZZ PHARMACEUTICALS INTERNAT III LTD·Filed 2014·Granted Jun 7, 2016·78 cites·22 claims
- 0796US9226910B2Treatment for obesityJAZZ PHARMACEUTICALS INTERNAT III LTD·Filed 2014·Granted Jan 5, 2016·74 cites·21 claims
- 0895US8741950B2Methods for treating or preventing fatigueKHAYRALLAH MOISE A·Filed 2010·Granted Jun 3, 2014·57 cites·15 claims
- 0993US11497725B2Treatment for obesityAXSOME MALTA LTD·Filed 2020·Granted Nov 15, 2022·2 cites·14 claims
- 1090US2025059135A1Treatment of cataplexyAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 1187US12162821B2Treatment of cataplexyAXSOME MALTA LTD·Filed 2023·Granted Dec 10, 2024·0 cites·20 claims
- 1287US9999609B2Methods for treating or preventing fatigueSK BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jun 19, 2018·2 cites·17 claims
- 1385US12201601B2Treatment for obesityAXSOME MALTA LTD·Filed 2022·Granted Jan 21, 2025·0 cites·24 claims
- 1483US9464041B2Methods for treating or preventing fatigueSK BIOPHARMACEUTICALS CO LTD·Filed 2014·Granted Oct 11, 2016·4 cites·28 claims
- 1579US11713292B2Treatment of cataplexyAXSOME MALTA LTD·Filed 2021·Granted Aug 1, 2023·0 cites·18 claims
- 1676US7884122B2Extended release formulation and method of treating adrenergic dysregulationSHIONOGI PHARMA INC·Filed 2009·Granted Feb 8, 2011·4 cites·10 claims
- 1775US2020061017A1Methods for treating or preventing fatigueSK BIOPHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 1871US10507192B2Methods for treating or preventing fatigue using O-carbamoyl-phenylalaninol compoundsSK BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted Dec 17, 2019·0 cites·8 claims
- 1963US2019099395A1Treatment for obesityJAZZ PHARMACEUTICALS INTERNATIONAL ILL LTD·Filed 2018·Application pending·0 cites
- 2060US2010209510A1Extended Release Formulation and Method of Treating Adrenergic DysregulationHORACEK HENRY JOSEPH·Filed 2009·Application pending·0 cites
- 2157US2009087490A1Extended release formulation and method of treating adrenergic dysregulationADDRENEX PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2253US2014128381A1Intranasal Benzodiazepine Pharmaceutical CompositionsSK BIOPHARMACEUTICALS CO LTD·Filed 2014·Application pending·0 cites
- 2348US2012252793A1Intranasal benzodiazepine pharmaceutical compositionsBREAM GARY·Filed 2012·Application pending·0 cites
- 2447US2017151258A1Intranasal benzodiazepine pharmaceutical compositionsACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2547US2011245314A1Extended Release Formulation and Methods of Treating Adrenergic DysregulationHORACEK HENRY JOSEPH·Filed 2011·Application pending·0 cites
- 2646US2010172991A1Extended Release Formulation and Methods of Treating Adrenergic DysregulationHORACEK HENRY JOSEPH·Filed 2009·Application pending·0 cites
- 2745US2015018414A1Promotion of Smoking CessationJAZZ PHARMACEUTICALS INTERNAT LLL LTD·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Moise A. Khayrallah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →